Non-commercial pharmaceutical R&D: what do neglected diseases suggest about costs and efficiency? [version 2; peer review: 2 approved, 1 approved with reservations]
Background: The past two decades have witnessed significant growth in non-commercial research and development (R&D) initiatives, particularly for neglected diseases, but there is limited understanding of the ways in which they compare with commercial R&D. This study analyses costs, timelines...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2021-08-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/10-190/v2 |